Qulu L, Daniels WM, Mabandla MV. Sersia chirindensis reverses the potentiating effect of prenatal stress on the development of febrile seizures and decreases plasma interleukin-1 beta levels. Neuroscience Research. 2016 Feb; 103:54-8.
Mpofana T, Daniels WM, Mabandla MV. Exposure to Early Life Stress Results in Epigenetic Changes in Neurotrophic Factor Gene Expression in a Parkinsonian Rat Model. Parkinson’s Disease. 2016, Article ID 6438783, 7 pages.
Mabandla MV, Nyoka M, Daniels WM. Early use of oleanolic acid provides protection against 6-hydroxydopamine induced dopamine neurodegeneration. Brain Research. 2015 October; 1622: 64-71
Ndlovu BC, Daniels WMU, Mabandla MV. Oleanolic acid enhances the beneficial effects of preconditioning on PC 12 cells. Parkinson’s Disease, 2014. Artlcle ID 929854, 1-5.
Mpofana T, Daniels WMU, Mabandla MV. Neuroprotective effects of caffeine on a maternally separated parkinsonian rat model. Journal of Behavioral and Brain Science, 2014; 4: 84-91.
Russell VA, Zigmond MJ, Dimatelis JJ, Daniels WM, Mabandla MV. The interaction between stress and exercise, and its impact on brain function. Metabolic Brain Disease. Metabolic Brain Disease. 2014 Jun: 29(2): 255-60.
Mohamed Moosa Z, Daniels WM, Mabandla MV. The effects of prenatal methylmercury exposure on trace element and antioxidant levels in rats following 6-hydroxydopamne-induced neuronal insult. Metabolic Brain Disease. Metabolic Brain Disease. 2014 Jun: 29(2): 459-69.
Musa V Mabandla, Bryony Dobson, Shula Johnson, Laurie A Kellaway, Willie MU Daniels, Vivienne A Russell. Development of a mild prenatal stress rat model to study long term effects on neural function and survival. Metab Brain Dis. 2008 Mar;23(1):31-42
Howells FM, Russell VA, Mabandla MV, Kellaway LA. Stress reduces the neuroprotective effect of exercise in a rat model for Parkinson’s disease (Behavioural Brain Research 165(2), 2005).
MV Mabandla, LA Kellaway, A St Slair Gibson and VA Russell. Voluntary running provides neuroprotection in rats following 6-hydroxydopamine injection into the medial forebrain bundle (Metabolic Brain Disease, 19 (1/2), 2004).